earthtimes.org
20-May-2008
SkyePharma Announces Presentation of FlutiformTM Phase III Safety Study at ATS in Toronto LONDON, UK, 20 May, 2008 - The author of the poster, Dr. Ekkehard Beck, stated "Study results suggest that long term treatment with FlutiformTM 100/10?g and FlutiformTM 250/10?g will be a safe therapy for...
[read full story]